Related Experiment Video
Updated: Jul 8, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect
Andrew R Hallahan1, Joel I Pritchard, Roshantha A S Chandraratna
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Abstract:
The mechanisms of retinoid activity in tumors remain largely unknown. Here we establish that retinoids cause extensive apoptosis of medulloblastoma cells. In a xenograft model, retinoids largely abrogated tumor growth. Using receptor-specific retinoid agonists, we defined a subset of mRNAs that were induced by all active retinoids in retinoid-sensitive cell lines. We also identified bone morphogenetic protein-2 (BMP-2) as a candidate mediator of retinoid activity. BMP-2 protein induced medulloblastoma cell apoptosis, whereas the BMP-2 antagonist noggin blocked both retinoid and BMP-2-induced apoptosis. BMP-2 also induced p38 mitogen-activated protein kinase (MAPK), which is necessary for BMP-2- and retinoid-induced apoptosis. Retinoid-resistant medulloblastoma cells underwent apoptosis when treated with BMP-2 or when cultured with retinoid-sensitive medulloblastoma cells. Retinoid-induced expression of BMP-2 is thus necessary and sufficient for apoptosis of retinoid-responsive cells, and expression of BMP-2 by retinoid-sensitive cells is sufficient to induce apoptosis in surrounding retinoid-resistant cells.
Insights
Retinoids induce apoptosis in medulloblastoma cells by activating bone morphogenetic protein-2 (BMP-2). This pathway also eliminates surrounding retinoid-resistant tumor cells, offering a novel therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Developmental Biology
Background:
- The precise mechanisms underlying retinoid efficacy in cancer therapy, particularly medulloblastoma, are not fully elucidated.
- Understanding retinoid signaling pathways is crucial for developing targeted cancer treatments.
Purpose of the Study:
- To investigate the molecular mechanisms by which retinoids induce apoptosis in medulloblastoma cells.
- To identify key mediators of retinoid-induced tumor suppression.
- To explore the potential of targeting retinoid pathways for medulloblastoma treatment.
Main Methods:
- Utilized receptor-specific retinoid agonists to identify retinoid-responsive gene expression.
- Employed a xenograft model to assess retinoid effects on tumor growth.
- Investigated the role of bone morphogenetic protein-2 (BMP-2) and p38 mitogen-activated protein kinase (MAPK) in retinoid-induced apoptosis.
Main Results:
- Retinoids were found to induce extensive apoptosis in medulloblastoma cells and significantly inhibit tumor growth in vivo.
- Bone morphogenetic protein-2 (BMP-2) was identified as a critical mediator, inducing apoptosis and activating p38 MAPK.
- BMP-2 expression by retinoid-sensitive cells was sufficient to induce apoptosis in surrounding retinoid-resistant cells.
Conclusions:
- Retinoid-induced BMP-2 expression is essential and sufficient for apoptosis in retinoid-responsive medulloblastoma cells.
- BMP-2 secreted by sensitive cells can eliminate adjacent resistant cells, suggesting a paracrine mechanism.
- This study elucidates a novel retinoid-BMP-2-MAPK signaling axis critical for medulloblastoma cell death and tumor control.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The Intrinsic Apoptotic Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

